Euroasian journal of hepato-gastroenterology

Register      Login

VOLUME 6 , ISSUE 1 ( January-June, 2016 ) > List of Articles


Past, Present, and Future of Viral Hepatitis in Bangladesh

Mamun Al-Mahtab

Citation Information : Al-Mahtab M. Past, Present, and Future of Viral Hepatitis in Bangladesh. Euroasian J Hepatogastroenterol 2016; 6 (1):43-44.

DOI: 10.5005/jp-journals-10018-1164

License: CC BY-NC 4.0

Published Online: 01-12-2017

Copyright Statement:  Copyright © 2016; The Author(s).


Viral hepatitis poses huge burden to the health care delivery system as well as to the economy of Bangladesh. Hepatitis E virus is the leading cause of acute hepatitis in this country, however with the improvement of economic status and sanitation this seems to be on the decline. Hepatitis B virus remains the leading cause in all forms of chronic liver diseases in this country. This virus has been extensively studied in Bangladesh, including from epidemiology to pathogenosis. Clinical trials with innovative therapy conducted in Bangladesh have shown promise. Hepatitis C virus follows hepatitis B virus as the second commonest cause of chronic liver diseases here. However patients in Bangladesh have started benefitting from the local generic versions of the newly introduced direct acting anti-virals.

PDF Share
  1. Mahtab MA, Rahman S, Foster G, Khan M, Karim MF, Solaiman S, Afroz S. Epidemiology of hepatitis B VIRUS in Bangladeshi general population. Hepatobiliary Pancreat Dis Int 2008 Dec;7(6):595-600
  2. HEV infection as an aetiologic factor for acute hepatitis: experience from a tertiary hospital in Bangladesh. J Health Popul Nutr 2009 Feb;27(1):14-19
  3. Aetiology of chronic hepatitis in Bangladesh. Indian J Gastroenterol 2007;26 (Suppl 2):142
  4. Hepatitis B virus is the leading cause of cirrhosis of liver in Bangladesh. Hepato Int 2007;1(Suppl 1):120
  5. Aetiology of SOL of liver in Bangladesh. Indian J Gastroenterol 2007;26(Suppl 2):76
  6. A phase III clinical trial with a nasal vaccine containing both HBsAg and HBcAg in patients with chronic hepatitis B. J Hepatolo 2013: 309, Abstract
  7. Prevalence and risk factors of asymptomatic HCV infection in Bangladesh. J Clin Experiment Hepatol 2011 Jun;1(2):13-16
  8. Features of hepatitis C virus infection, current therapies and ongoing clinical trials in 10 Asian Pacific countries. Hepatol Int 2015 Oct;9(4):486-507
  9. Genotypes of HCV in Bangladesh: experience from a tertiary centre. Hungarian Med J 2008;2(4):577-581
  10. RVR response in HCV related compensated CLD with triple therapy containing sofosbuvir in Bangladesh. Hepatol Int 2015;(Suppl) (in press)
  11. Epidemiological and molecular analyses of a non-seasonal outbreak of acute icteric hepatitis E in Bangladesh. J Med Virol 2013 Aug;85(8):1369-1376
  12. Hepatitis E virus is the leading cause of acute-on-chronic liver disease: Experience from a tertiary centre in Bangladesh. Hepato Biliar Pancreat Dis Int 2009 Feb;8(1):50-52
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.